Herpes Labialis (Oral Herpes) drugs in development, 2023

GlobalData tracks 15 drugs in development for Herpes Labialis (Oral Herpes) by 11 companies/universities/institutes. The top development phase for Herpes Labialis (Oral Herpes) is preclinical, with six drugs in that stage.

Therapeutic Potential of Psychedelics for Older Adults | Psychedelic Invest

Psychedelics such as DMT, LSD, and psilocybin have shown significant potential in treating affective symptoms across a variety of disorders. These substances induce altered states

July 22, 2024

Sinusitis Tied to Later Autoimmune Disease

A history of sinus congestion and drip may be a precursor to serious autoimmune disorders, a population-based study suggested. Rates of rheumatologic conditions including antiphospholipid

February 28, 2024

A nonprofit does deals in Brazil and India to make low-cost CAR-T cell therapies widely available

In the latest bid to widen access to medicines, a nonprofit is sending technology and materials for making expensive CAR-T cell therapies to the Brazilian

May 8, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.